Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021
Research

Spotted Fever Group Rickettsioses in Israel, 2010–2019

Regev CohenComments to Author , Talya Finn, Frida Babushkin, Yael Paran, Ronen Ben Ami, Alaa Atamna, Sharon Reisfeld, Gabriel Weber, Neta Petersiel, Hiba Zayyad, Eyal Leshem, Miriam Weinberger, Yasmin Maor, Nicola Makhoul, Lior Nesher, Galia Zaide, Dar Klein, Adi Beth-Din, and Yafit Atiya-Nasagi
Author affiliations: Laniado Hospital, Netanya, Israel (R. Cohen, T. Finn, F. Babushkin); Technion–Israel Institute of Technology, Haifa, Israel (R. Cohen, T. Finn, S. Reisfeld, G. Weber); Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel (Y. Paran, R. Ben Ami); Tel Aviv University, Tel Aviv (Y. Paran, R. Ben Ami, A. Atamna, E. Leshem, M. Weinberger, Y. Maor); Rabin Medical Centre, Petah-Tikva, Israel (A. Atamna); Hillel Yaffe Medical Centre, Hadera, Israel (S. Reisfeld); Carmel Medical Centre, Haifa (G. Weber); Rambam Medical Centre, Haifa (N. Petersiel); Padeh Poriya Medical Centre, Tiberias, Israel (H. Zayyad); Bar Ilan University, Safed, Israel (H. Zayyad, N. Makhoul); S; heba Medical Centre, Ramat Gan, Israel (E. Leshem); Shamir (formerly Assaf Harofeh) Medical Center, Zerifin, Israel (M. Weinberger); Edith Wolfson Medical Centre, Holon, Israel (Y. Maor); Galilee Medical Centre, Nahariya, Israel (N. Makhoul); Soroka Medical Centre, Beer Sheba, Israel (L. Nesher); Ben-Gurion University of the Negev, Beer Sheba (L. Nesher); Israel Institute for Biological Research, Ness Ziona, Israel (G. Zaide, D. Klein, A. Beth-Din, Y. Atiya-Nasagi)

Main Article

Table 2

Demographics and epidemiologic data for patients with spotted fever group rickettsiosis, according to rickettsial species, Israel, 2010–2019*

Patient data
R. conorii Israeli tick typhus strain
 R. conorii Malish strain
 R. africae
 New Rickettsia variant
 Total
 p value
No. cases
 33
 2
 4
 3
 42
Age, y, median (IQR)
 48 (18–64)
 38
 55.5 (52.5–64)
 66
 50.5 (26–66)
 NS
Sex
M 20 (61) 1 (50) 2 (50) 2 (67) 25 (60) NS
F
 13 (39)
 1 (50)
 2 (50)
 1 (33)
 17 (40)
 NS
Any previous medical condition† 17 (51) 1 (50) 1 (25) 2 (66) 21 (50) NS
Diabetes mellitus 6 (18) 1 (50) 0 1 (33) 8 (19) NS
Dyslipidemia 7 (21) 0 0 1 (33) 8 (19) NS
Hypertension 7 (21) 0 0 0 7 (17) NS
Obesity 3 (9) 0 0 0 3 (7) NS
COPD 1 (3) 0 1 (25) 1 (33) 3 (7) NS
Chronic liver disease 1 (3) 1 (50) 0 0 2 (5) NS
Alcohol abuse 3 (9) 0 0 0 3 (7) NS
Psychiatric disorder/dementia 3 (9) 0 0 0 3 (7) NS
Drug abuse 2 (6) 0 0 0 2 (5) NS
Congestive heart failure 2 (6) 0 0 0 2 (5) NS
Chronic renal failure
 1 (3)
 0
 0
 0
 1 (2.5)
 NS
Exposure history
Tick 2 (6) 0 0 0 2 (5) NS
Animals, species 20 (60),
17 dogs, 4 cats, 2 rats, 2 sheep, 1 cow)		 0 2 (50),1 dog, 1 African safari 3 (100),
2 dogs, 1 cat		 25 (59) NS
Recent overseas travel 1 (3), to Cyprus 1 (50), to India 4 (100), to Africa 0 6 (14) <0.0001

*Values are no. (%) unless otherwise indicated. COPD, chronic obstructive pulmonary disease; IQR, interquartile range; NS, not significant (p>0.05). †Includes all conditions described in the table except previous stroke, previous nonactive malignancy, atrial fibrillation, active malignancy, or immunosuppression.

Main Article

Page created: June 09, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external